한글목차

세계 신경혈관 색전 기기 시장은 2018년 10억 6,641만 달러로 평가되었으며, 2023년까지 연평균 3.0% 이상의 연평균 성장률(CAGR)을 나타낼 것으로 예상됩니다.

신경혈관질환에 대한 인식 제고

실적 기간 동안 신경혈관질환에 대한 인식이 높아지면서 신경혈관 색전 기기이 성장세를 이어갔습니다. 뇌졸중 및 동맥류와 같은 질환에 대한 인식이 높아짐에 따라 진단 건수가 증가하고 효과적인 치료 옵션에 대한 수요가 증가했습니다. 인식 개선 캠페인과 교육 이니셔티브가 조기 개입의 중요성을 강조함에 따라 고급 신경혈관 색전술에 대한 수요가 급증했습니다. 이러한 인식 증가는 잠재적 환자층을 확대시키고 신경혈관 질환의 진단 및 관리를 위해 설계된 기기의 채택을 촉진했습니다. 예를 들어, 워싱턴 대학교 시애틀의 건강 측정 및 평가 연구소(Institute for Health Metrics and Evaluation, IHME)가 주도하는 종합적인 이니셔티브인 Global Burden of Diseases, Injuries and Risk Factors Study(GBD)( GBD)에 따르면, 2021년에는 34억 명 이상(전 세계 인구의 40% 이상)이 신경질환의 영향을 받을 것으로 예상했습니다. 이 연구는 37개의 신경질환이 전 세계적으로 4억 4,300만 명의 장애 조정 생존년수(DALY)와 1,110만 명의 사망을 유발하고 있으며, 이러한 영향의 약 80%가 중저소득 국가에서 발생한다는 점을 강조했습니다.

목차

제1장 주요 요약

• 신경혈관 색전 기기 - 시장의 매력과 거시경제 상황

제2장 목차

제3장 표 리스트

제4장 그래프 리스트

제5장 보고서 구성

제6장 시장 특징

• 일반적인 시장의 정의
• 개요
• 신경혈관 색전 기기 시장 정의와 세분화
• 시장 세분화 : 제품별
  • 색전코일
  • 액체 색전 시스템
  • 혈류 전환 스텐트
  • 동맥류 클립
  • 기타 제품
• 시장 세분화 : 치료별
  • 허혈성 뇌졸중 솔루션
  • 출혈성 뇌졸중 솔루션
• 시장 세분화 : 적응증별
  • 뇌동맥류
  • 동정맥기형
  • 기타 적응증
• 시장 세분화 : 최종사용자별
  • 병원
  • 외래수술센터(ASC)
  • 기타 최종사용자

제7장 주요 시장 동향

제8장 신경혈관 색전 기기 시장 - 거시경제 시나리오

• COVID-19의 영향 : 신경혈관 색전 기기 시장
• 우크라이나 전쟁의 영향 : 신경혈관 색전 기기 시장
• 고인플레이션의 영향 : 신경혈관 색전 기기 시장

제9장 세계 시장 규모와 성장

• 시장 규모
• 시장 성장 실적, 2018년-2023년
  • 시장 성장 촉진요인, 2018년-2023년
  • 시장 성장 억제요인, 2018년-2023년
• 시장 성장 예측, 2023년-2028년, 2033년
  • 시장 성장 촉진요인, 2023년-2028년
  • 시장 성장 억제요인, 2023년-2028년

제10장 세계의 신경혈관 색전 기기 시장 : 세분화

• 세계의 신경혈관 색전 기기 시장 : 제품별, 분석과 예측, 2018년-2023년, 2028년, 2033년
• 세계의 신경혈관 색전 기기 시장 : 치료별, 분석과 예측, 2018년-2023년, 2028년, 2033년
• 세계의 신경혈관 색전 기기 시장 : 최종사용자별, 분석과 예측, 2018년-2023년, 2028년, 2033년
• 세계의 신경혈관 색전 기기 시장 : 적응증별, 분석과 예측, 2018년-2023년, 2028년, 2033년

제11장 신경혈관 색전 기기 시장 : 지역·국가별 분석

• 세계의 신경혈관 색전 기기 시장 : 지역별, 분석과 예측, 2018년-2023년, 2028년, 2033년
• 세계의 신경혈관 색전 기기 시장 : 국가별, 분석과 예측, 2018년-2023년, 2028년, 2033년

제12장 아시아태평양 시장

제13장 서유럽 시장

제14장 동유럽 시장

제15장 북미 시장

제16장 남미 시장

제17장 중동 시장

제18장 아프리카 시장

제19장 경쟁 구도와 기업 개요

• 기업 개요
• Terumo Corporation
• Medtronic Inc
• Penumbra Inc
• Stryker Corporation
• Johnson & Johnson

제20장 기타 주요 기업 및 혁신 기업

• Cook Medical LLC
• Abbott Laboratories
• MicroPort
• Asahi Intecc Co Ltd
• Boston Scientific Corporation
• Merit Medical Systems, Inc
• InNeuroCo Inc
• B. Braun Melsungen AG
• BALT Group
• Acandis GmbH
• Wallaby Medical(Phenox GmbH)
• Heraeus
• Integra LifeSciences Corporation
• Shape Memory Medical
• NeuroVasc Technologies, Inc

제21장 주요 인수합병(M&A)

• Stryker Corporation Acquired Cerus Endovascular Ltd
• Boston Scientific Corporation Acquired Obsidio, Inc
• Wallaby Medical Acquired Phenox GmbH

제22장 기회와 전략

• 세계의 신경혈관 색전 기기 시장, 2028년 : 새로운 기회를 제공하는 국가
• 세계의 신경혈관 색전 기기 시장, 2028년 : 새로운 기회를 제공하는 부문
• 세계의 신경혈관 색전 기기 시장, 2028년 : 성장 전략
  • 시장 동향에 근거한 전략
  • 경쟁 전략

제23장 신경혈관 색전 기기 시장 : 결론과 제안

• 결론
• 제안
  • 제품
  • 장소
  • 가격
  • 프로모션
  • 사람들

제24장 부록

영문목차

neurovascular conditions, particularly those involving abnormal blood flow in the brain. These devices are designed to prevent or reduce blood flow to problematic areas, such as aneurysms, arteriovenous malformations (AVMs) or other vascular abnormalities in the brain. By effectively stopping blood flow to these targeted areas, neurovascular embolization devices help to prevent hemorrhages, reduce bleeding risks and stabilize or resolve potentially life-threatening vascular abnormalities.

The neurovascular embolization devices market consists of sales, by entities (organizations, sole traders and partnerships), of neurovascular embolization devices that are used to treat conditions affecting the blood vessels in the brain.

The global neurovascular embolization devices market was valued at $1,066.41 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 3.0%.

Increasing Awareness Of Neurovascular Disorders

During the historic period, the increasing awareness of neurovascular disorders has driven the neurovascular embolization devices market. The growing recognition of conditions such as stroke and aneurysms led to more diagnoses and a higher demand for effective treatment options. As awareness campaigns and educational initiatives emphasized the importance of early intervention, the need for advanced neurovascular embolization devices surged. This heightened awareness expanded the potential patient population and drove up the adoption of devices designed for the diagnosis and management of neurovascular conditions. For example, in 2021, according to the Global Burden of Diseases, Injuries and Risk Factors Study (GBD), a comprehensive initiative led by the Institute for Health Metrics and Evaluation (IHME) at the University of Washington, Seattle, over 3.4 billion people-more than 40% of the global population-were affected by neurological disorders. The study highlighted that 37 neurological conditions were responsible for 443 million disability-adjusted life-years (DALYs) and 11.1 million deaths globally, with around 80% of these impacts occurring in low- and middle-income countries.

Launch Of Innovative Low-Profile Visualized Intraluminal Support Devices

Major companies operating in the neurovascular embolization devices market are focusing on launching innovative low-profile visualized intraluminal support devices that deliver enhanced imaging clarity during procedures, enabling accurate placement and precise control over deployment. For instance, in June 2024, MicroVention Inc, a US-based company that provides neurovascular embolization devices, announced the launch of its LVIS(TM) EVO(TM) (Low-Profile Visualized Intraluminal Support) Intraluminal Support Device, specifically designed for the treatment of wide-neck intracranial aneurysms in patients aged 18 and above. This stent is distinguished as the first fully visible coil-assist intracranial stent available in the US market, offering enhanced visibility under fluoroscopy, which facilitates accurate placement and controlled deployment. The LVIS(TM) EVO(TM) incorporates advanced design features, including Drawn Filled Tube (DFT) wire construction and an optimized braid angle, enabling improved opening and the capacity to resheath up to 80% of its length.

The global neurovascular embolization devices market is concentrated, with a few large players operating in the market. The top ten competitors in the market made up to 40.6% of the total market in 2023.

Neurovascular Embolization Devices Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global neurovascular embolization devices market as it emerges from the COVID-19 shut down.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for neurovascular embolization devices? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The neurovascular embolization devices market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider neurovascular embolization devices market; and compares it with other markets.

The report covers the following chapters

• Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product, by treatment, by indication and by end-user.
• Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
• Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the neurovascular embolization devices market.
• Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
• Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
• Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by product, by treatment, by indication and by end-user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
• Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
• Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
• Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
• Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
• Competitive Dashboard- Briefs on competitive dashboard of major players.
• Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
• Conclusions And Recommendations- This section includes recommendations for neurovascular embolization devices providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
• Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

• 1) By Product: Embolization Coils; Liquid Embolic Systems; Flow Diversion Stents; Aneurysm Clips; Other Products
• 2) By Treatment: Ischemic Stroke Solution; Hemorrhagic Stroke Solutions
• 3) By End-User: Hospitals; Ambulatory Surgical Centers; Other End Users
• 4) By Indication: Brain Aneurysms; Arteriovenous Malformation; Other Indications
• Companies Mentioned: Terumo Corporation;Medtronic Plc;Penumbra Inc; Stryker Corporation;Johnson & Johnson
• Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time-series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; neurovascular embolization devices indicators comparison
• Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

• 1.1 Neurovascular Embolization Devices - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

• 6.1 General Market Definition
• 6.2 Summary
• 6.3 Neurovascular Embolization Devices Market Definition And Segmentations
• 6.4 Market Segmentation By Product
  • 6.4.1 Embolization Coils
  • 6.4.2 Liquid Embolic Systems
  • 6.4.3 Flow Diversion Stents
  • 6.4.4 Aneurysm Clips
  • 6.4.5 Other Products
• 6.5 Market Segmentation By Treatment
  • 6.5.1 Ischemic Stroke Solutions
  • 6.5.2 Hemorrhagic Stroke Solutions
• 6.6 Market Segmentation By Indication
  • 6.6.1 Brain Aneurysms
  • 6.6.2 Arteriovenous Malformation
  • 6.6.3 Other Indications
• 6.7 Market Segmentation By End-User
  • 6.7.1 Hospitals
  • 6.7.2 Ambulatory Surgical Centers
  • 6.7.3 Other End-Users

7 Major Market Trends

• 7.1 Launch Of Innovative Low-Profile Visualized Intraluminal Support Devices
• 7.2 New Neurovascular Devices For Ischemic And Hemorrhagic Stroke Management
• 7.3 Innovations In Catheter Design For Complex Neurovascular Anatomy
• 7.4 Advanced Embolic System Enhances Minimally Invasive Procedures

8 Neurovascular Embolization Devices Market - Macro-Economic Scenario

• 8.1 COVID-19 Impact On The Neurovascular Embolization Devices Market
• 8.2 Impact Of The War In Ukraine On The Neurovascular Embolization Devices Market
• 8.3 Impact Of High Inflation On The Neurovascular Embolization Devices Market

9 Global Market Size and Growth

• 9.1 Market Size
• 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
  • 9.2.1 Market Drivers 2018 - 2023
  • 9.2.2 Market Restraints 2018 - 2023
• 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
  • 9.3.1 Market Drivers 2023 - 2028
  • 9.3.2 Market Restraints 2023 - 2028

10 Global Neurovascular Embolization Devices Market Segmentation

• 10.1 Global Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 10.2 Global Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 10.3 Global Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 10.4 Global Neurovascular Embolization Devices Market, Segmentation By Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Neurovascular Embolization Devices Market, Regional and Country Analysis

• 11.1 Global Neurovascular Embolization Devices Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 11.2 Global Neurovascular Embolization Devices Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

• 12.1 Summary
• 12.2 Market Overview
  • 12.2.1 Region Information
  • 12.2.2 Market Information
  • 12.2.3 Background Information
  • 12.2.4 Government Initiatives
  • 12.2.5 Regulations
  • 12.2.6 Regulatory Bodies
  • 12.2.7 Major Associations
  • 12.2.8 Taxes Levied
  • 12.2.9 Corporate Tax Structure
  • 12.2.10 Investments
  • 12.2.11 Major Companies
• 12.3 Asia Pacific Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.4 Asia Pacific Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.5 Asia Pacific Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.6 Asia-Pacific Neurovascular Embolization Devices Market: Country Analysis
• 12.7 China Market
• 12.8 Summary
• 12.9 Market Overview
  • 12.9.1 Country Information
  • 12.9.2 Market Information
  • 12.9.3 Background Information
  • 12.9.4 Government Initiatives
  • 12.9.5 Regulations
  • 12.9.6 Regulatory Bodies
  • 12.9.7 Major Associations
  • 12.9.8 Taxes Levied
  • 12.9.9 Corporate Tax Structure
  • 12.9.10 Investments
  • 12.9.11 Major Companies
• 12.10 China Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.11 China Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.12 China Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.13 India Market
• 12.14 India Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.15 India Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.16 India Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.17 Japan Market
• 12.18 Japan Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.19 Japan Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.20 Japan Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.21 Australia Market
• 12.22 Australia Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.23 Australia Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.24 Australia Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.25 Indonesia Market
• 12.26 Indonesia Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.27 Indonesia Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.28 Indonesia Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.29 South Korea Market
• 12.30 South Korea Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.31 South Korea Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 12.32 South Korea Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

• 13.1 Summary
• 13.2 Market Overview
  • 13.2.1 Region Information
  • 13.2.2 Market Information
  • 13.2.3 Background Information
  • 13.2.4 Government Initiatives
  • 13.2.5 Regulations
  • 13.2.6 Regulatory Bodies
  • 13.2.7 Major Associations
  • 13.2.8 Taxes Levied
  • 13.2.9 Corporate Tax Structure
  • 13.2.10 Investments
  • 13.2.11 Major Companies
• 13.3 Western Europe Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.4 Western Europe Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.5 Western Europe Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.6 Western Europe Neurovascular Embolization Devices Market: Country Analysis
• 13.7 UK Market
• 13.8 UK Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.9 UK Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.10 UK Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.11 Germany Market
• 13.12 Germany Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.13 Germany Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.14 Germany Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.15 France Market
• 13.16 France Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.17 France Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.18 France Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.19 Italy Market
• 13.20 Italy Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.21 Italy Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.22 Italy Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.23 Spain Market
• 13.24 Spain Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.25 Spain Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 13.26 Spain Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

• 14.1 Summary
• 14.2 Market Overview
  • 14.2.1 Region Information
  • 14.2.2 Market Information
  • 14.2.3 Background Information
  • 14.2.4 Government Initiatives
  • 14.2.5 Regulations
  • 14.2.6 Regulatory Bodies
  • 14.2.7 Major Associations
  • 14.2.8 Taxes Levied
  • 14.2.9 Corporate Tax Structure
  • 14.2.10 Investments
  • 14.2.11 Major Companies
• 14.3 Eastern Europe Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.4 Eastern Europe Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.5 Eastern Europe Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.6 Eastern Europe Neurovascular Embolization Devices Market: Country Analysis
• 14.7 Russia Market
• 14.8 Russia Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.9 Russia Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 14.10 Russia Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

• 15.1 Summary
• 15.2 Market Overview
  • 15.2.1 Region Information
  • 15.2.2 Market Information
  • 15.2.3 Background Information
  • 15.2.4 Government Initiatives
  • 15.2.5 Regulations
  • 15.2.6 Regulatory Bodies
  • 15.2.7 Major Associations
  • 15.2.8 Taxes Levied
  • 15.2.9 Corporate Tax Structure
  • 15.2.10 Investments
  • 15.2.11 Major Companies
• 15.3 North America Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.4 North America Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.5 North America Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.6 North America Neurovascular Embolization Devices Market: Country Analysis
• 15.7 USA Market
• 15.8 Summary
• 15.9 Market Overview
  • 15.9.1 Country Information
  • 15.9.2 Market Information
  • 15.9.3 Background Information
  • 15.9.4 Government Initiatives
  • 15.9.5 Regulations
  • 15.9.6 Regulatory Bodies
  • 15.9.7 Major Associations
  • 15.9.8 Taxes Levied
  • 15.9.9 Corporate Tax Structure
  • 15.9.10 Investments
  • 15.9.11 Major Companies
• 15.10 USA Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.11 USA Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.12 USA Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.13 Canada Market
• 15.14 Canada Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.15 Canada Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 15.16 Canada Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

• 16.1 Summary
• 16.2 Market Overview
  • 16.2.1 Region Information
  • 16.2.2 Market Information
  • 16.2.3 Background Information
  • 16.2.4 Government Initiatives
  • 16.2.5 Regulations
  • 16.2.6 Regulatory Bodies
  • 16.2.7 Major Associations
  • 16.2.8 Taxes Levied
  • 16.2.9 Corporate Tax Structure
  • 16.2.10 Investments
  • 16.2.11 Major Companies
• 16.3 South America Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.4 South America Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.5 South America Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.6 South America Neurovascular Embolization Devices Market: Country Analysis
• 16.7 Brazil Market
• 16.8 Brazil Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.9 Brazil Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 16.10 Brazil Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

• 17.1 Summary
• 17.2 Market Overview
  • 17.2.1 Region Information
  • 17.2.2 Market Information
  • 17.2.3 Background Information
  • 17.2.4 Government Initiatives
  • 17.2.5 Regulations
  • 17.2.6 Regulatory Bodies
  • 17.2.7 Major Associations
  • 17.2.8 Taxes Levied
  • 17.2.9 Corporate Tax Structure
  • 17.2.10 Investments
  • 17.2.11 Major Companies
• 17.3 Middle East Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 17.4 Middle East Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 17.5 Middle East Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

• 18.1 Summary
• 18.2 Market Overview
  • 18.2.1 Region Information
  • 18.2.2 Market Information
  • 18.2.3 Background Information
  • 18.2.4 Government Initiatives
  • 18.2.5 Regulations
  • 18.2.6 Regulatory Bodies
  • 18.2.7 Major Associations
  • 18.2.8 Taxes Levied
  • 18.2.9 Corporate Tax Structure
  • 18.2.10 Investments
  • 18.2.11 Major Companies
• 18.3 Africa Neurovascular Embolization Devices Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 18.4 Africa Neurovascular Embolization Devices Market, Segmentation By Treatment, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
• 18.5 Africa Neurovascular Embolization Devices Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

• 19.1 Company Profiles
• 19.2 Terumo Corporation
  • 19.2.1 Company Overview
  • 19.2.2 Products And Services
  • 19.2.3 Business Strategy
  • 19.2.4 Financial Overview
• 19.3 Medtronic Inc
  • 19.3.1 Company Overview
  • 19.3.2 Products And Services
  • 19.3.3 Business Strategy
  • 19.3.4 Financial Overview
• 19.4 Penumbra Inc
  • 19.4.1 Company Overview
  • 19.4.2 Products And Services
  • 19.4.3 Business Strategy
  • 19.4.4 Financial Overview
• 19.5 Stryker Corporation
  • 19.5.1 Company Overview
  • 19.5.2 Products And Services
  • 19.5.3 Business Strategy
  • 19.5.4 Financial Overview
• 19.6 Johnson & Johnson
  • 19.6.1 Company Overview
  • 19.6.2 Products And Services
  • 19.6.3 Business Strategy
  • 19.6.4 Financial Overview

20 Other Major And Innovative Companies

• 20.1 Cook Medical LLC
  • 20.1.1 Company Overview
  • 20.1.2 Products And Services
• 20.2 Abbott Laboratories
  • 20.2.1 Company Overview
  • 20.2.2 Products And Services
• 20.3 MicroPort
  • 20.3.1 Company Overview
  • 20.3.2 Products And Services
• 20.4 Asahi Intecc Co Ltd
  • 20.4.1 Company Overview
  • 20.4.2 Products And Services
• 20.5 Boston Scientific Corporation
  • 20.5.1 Company Overview
  • 20.5.2 Products And Services
• 20.6 Merit Medical Systems, Inc
  • 20.6.1 Company Overview
  • 20.6.2 Products And Services
• 20.7 InNeuroCo Inc
  • 20.7.1 Company Overview
  • 20.7.2 Products And Services
• 20.8 B. Braun Melsungen AG
  • 20.8.1 Company Overview
  • 20.8.2 Products And Services
• 20.9 BALT Group
  • 20.9.1 Company Overview
  • 20.9.2 Products And Services
• 20.10 Acandis GmbH
  • 20.10.1 Company Overview
  • 20.10.2 Products And Services
• 20.11 Wallaby Medical (Phenox GmbH)
  • 20.11.1 Company Overview
  • 20.11.2 Products And Services
• 20.12 Heraeus
  • 20.12.1 Company Overview
  • 20.12.2 Products And Services
• 20.13 Integra LifeSciences Corporation
  • 20.13.1 Company Overview
  • 20.13.2 Products And Services
• 20.14 Shape Memory Medical
  • 20.14.1 Company Overview
  • 20.14.2 Products And Services
• 20.15 NeuroVasc Technologies, Inc
  • 20.15.1 Company Overview
  • 20.15.2 Products And Services

21 Key Mergers And Acquisitions

• 21.1 Stryker Corporation Acquired Cerus Endovascular Ltd
• 21.2 Boston Scientific Corporation Acquired Obsidio, Inc
• 21.3 Wallaby Medical Acquired Phenox GmbH

22 Opportunities And Strategies

• 22.1 Global Neurovascular Embolization Devices Market In 2028 - Countries Offering Most New Opportunities
• 22.2 Global Neurovascular Embolization Devices Market In 2028 - Segments Offering Most New Opportunities
• 22.3 Global Neurovascular Embolization Devices Market In 2028 - Growth Strategies
  • 22.3.1 Market Trend Based Strategies
  • 22.3.2 Competitor Strategies

23 Neurovascular Embolization Devices Market, Conclusions And Recommendations

• 23.1 Conclusions
• 23.2 Recommendations
  • 23.2.1 Product
  • 23.2.2 Place
  • 23.2.3 Price
  • 23.2.4 Promotion
  • 23.2.5 People

24 Appendix

• 24.1 Geographies Covered
• 24.2 Market Data Sources
• 24.3 Research Methodology
• 24.4 Currencies
• 24.5 The Business Research Company
• 24.6 Copyright and Disclaimer